Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$490,194
+$10,629 QoQ
Shares Held
1,948
-11.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#3,175
of 4,153 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JMN Financial LLC holds $5,614,202 across 9 Drug Manufacturers - General names. ABBV ranks #5 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
981 | $1,176,640 | |
| 2 | JNJ |
Johnson & Johnson
|
4,520 | $1,147,944 | |
| 3 | NVS |
Novartis AG
|
5,089 | $797,548 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
3,977 | $502,454 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
1,948 | $490,194 | |
| 6 | GSK |
GSK plc
|
7,697 | $403,476 | |
| 7 | AMGN |
Amgen Inc
|
1,103 | $399,418 | |
| 8 | MRK |
Merck & Co., Inc.
|
3,048 | $391,668 |
All Filings in ABBV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $490,194 | 1,948 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $479,565 | 2,205 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $569,625 | 2,493 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||